Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-20

Clinical Trial Update: BENDITA BEnznidazole New Doses Improved Treatment and Associations [Phase 2]

View source ↗

Summary

Phase 2 update on Bendita benznidazole new doses showing improved treatment and associations for Chagas disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BENDITA BEnznidazole (benznidazole)

Snippet

Sponsor: Drugs for Neglected Diseases | Conditions: Chagas Disease | Phase 2 | Status: UNKNOWN